A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study
Servizos
Servizos
Data de publicación
2013Título da revista
Annals of the rheumatic diseases
Tipo de contido
Publicación de congreso
